阿奇霉素在小儿肺炎支原体性肺炎中的应用效果分析
苏韩【摘要】目的:分析对肺炎支原体性肺炎患儿给予阿奇霉素治疗的效果。方法:选择2020年7月—2022年4月到本院进行治疗的102例肺炎支原体性肺炎患儿进行研究,根据治疗药物实施分组,将其分为阿奇霉素组和红霉素组,每组各51例。红霉素组患儿选择接受红霉素治疗,阿奇霉素组患儿选择接受阿奇霉素治疗,比较阿奇霉素组和红霉素组患儿的临床指标、治疗效果,同时比较阿奇霉素组和红霉素组的药物副作用出现情况。结果:阿奇霉素组患儿的临床指标均明显短于红霉素组患儿,差异显著(P<0.05);阿奇霉素组患儿的治疗效果明显比红霉素组患儿高,差异显著(P<0.05);阿奇霉素组和红霉素组的肝功能异常、腹痛、呕吐、腹泻以及恶心等副作用出现率没有显著差异(P>0.05)。结论:对肺炎支原体性肺炎患儿给予阿奇霉素治疗,能使患儿的治疗效果得到提升,且副作用较低,具有较高的应用价值,值得推广。
【关键词】红霉素;肺炎支原体性肺炎;阿奇霉素
Analysis of the application effect of azithromycin in children with mycoplasma pneumoniae pneumonia
SU Han
People’s Hospital of Weining County, Guizhou, Weining, Guizhou 553100, China
【Abstract】Objective:To analyze the effect of azithromycin therapy on children with mycoplasma pneumoniae pneumonia.Methods:A total of 102 children with mycoplasma pneumoniae pneumonia who were treated in our hospital from July 2020 to April 2022 were selected for research.They were divided into azithromycin group and erythromycin group according to the implementation of treatment drugs ......
您现在查看是摘要页,全文长 8663 字符。